Enteric Disease Testing Market Growth, Demand and Challenges of the Key Industry Players

1
Global Enteric Disease Testing Market Research
and Forecast Report 2021-2026




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Enteric Disease Testing Market Research
Report According to the latest IMARC Group
report, titled Enteric Disease Testing Market
Global Industry Trends, Share, Size, Growth,
Opportunity and Forecast 2021-2026, the global
enteric disease testing market reached a strong
growth in 2020.  Enteric diseases are caused by
the ingestion of food or water contaminated by
microbial toxins and microorganisms. These
microorganisms enter through the mouth by coming
in contact with an infected person's feces or
with animals and their environments, attacking
the gastrointestinal tract. Enteric diseases
can cause symptoms like diarrhea, nausea,
vomiting, fever, chills, abdominal cramps, and a
loss of appetite. In recent years, the approval
for the commercialization of novel technologies
and the launch of new products have
revolutionized enteric disease testing. Request
Free Sample Report https//www.imarcgroup.com/ent
eric-disease-testing-market/requestsample
4
Report Description and Highlights
Report Description
Global Enteric Disease Testing Market Trends
The increasing cases of enteric diseases, such
as cholera, amebiasis, Campylobacteriosis and
Hepatitis A, represent the primary factor that
positively impacts the global enteric disease
testing market. This can be attributed to the
unhygienic conditions, unsafe drinking water and
poor sanitation. Besides this, with the recent
outbreak of coronavirus disease (COVID-19),
testing for enteric diseases has increased as the
virus is variably found in human enteric samples
during the course of infection. As a result, many
healthcare centers are undertaking research to
discover the co-relation between enteric disease
and COVID-19. Furthermore, as individuals are
becoming more aware of the benefits of early
diagnosis, they are increasingly opting for the
testing of enteric diseases. The leading
healthcare companies are investing in research
and development (RD) activities to advance the
enteric disease testing technologies to increase
the efficiency of diagnosis. Some of the other
factors, such as improving healthcare
infrastructure, various technological
advancements and the emerging trend of medical
tourism, are expected to create a positive
outlook for the market. Looking forward, the
market value is projected to reach a strong
growth during the forecast period (2021-2026).

5
Report Description and Highlights
Report Description

• Market Summary
• Breakup by Product Type
• Reagents and Consumables
• Equipment
•  
• Breakup by Technique
• Molecular Diagnostics
• Immunodiagnostics
• Breakup by Disease Type
• Bacterial Enteric Disease
• C. Difficile
• Campylobacteriosis
• Cholera
• E. Coli
• H. Pylori
• Salmonellosis
• Shigellosis
• Viral Enteric Disease

6
Report Description and Highlights
Report Description

• Others
• Parasitic Enteric Disease
• Amebiasis
• Cryptosporidiosis
• Giardiasis
• Breakup by End User
• Hospital Diagnostic Laboratories
• Independent Diagnostic Laboratories
• Academic and Research Institutes
• Others
• Breakup by Region
• North America
• United States
• Canada
• Asia Pacific
• China
• Japan

7
Report Description and Highlights
Report Description

• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Argentina
• Columbia
• Chile
• Peru

8
Report Description and Highlights
Report Description

• Middle East and Africa Turkey
• Saudi Arabia
• Iran
• United Arab Emirates
• Others
• We are updating our reports, If you want latest
  primary and secondary data (2021-2026) with Cost
  Module, Business Strategy, Distribution Channel,
  etc. Click request free sample report.
• Competitive Landscape with Key Players
• Abbott Laboratories
• BD (Becton, Dickinson and Company)
• Bio-Rad Laboratories Inc.
• Biomerica Inc.
• Biomérieux SA
• Cepheid Inc. (Danaher Corporation)
• Coris BioConcept
• DiaSorin
• Meridian Bioscience Inc.
• Quest Diagnostics.

9
Report Description and Highlights
Report Description

View Full Report with TOC List of Figure
https//www.imarcgroup.com/enteric-disease-testing
-market
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
12
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
13

Contact Us